Cargando…
COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
BACKGROUND AND OBJECTIVES: There are limited data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine reactogenicity in persons with multiple sclerosis (PwMS) and how reactogenicity is affected by disease-modifying therapies (DMTs). The objective of this retrospective cross-secti...
Autores principales: | Briggs, Farren Basil Shaw, Mateen, Farrah J., Schmidt, Hollie, Currie, Keisha M., Siefers, Heather M., Crouthamel, Slavka, Bebo, Bruce F., Fiol, Julie, Racke, Michael K., O'Connor, Kevin C., Kolaczkowski, Laura G., Klein, Phyllis, Loud, Sara, McBurney, Robert Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579248/ https://www.ncbi.nlm.nih.gov/pubmed/34753828 http://dx.doi.org/10.1212/NXI.0000000000001104 |
Ejemplares similares
-
Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study
por: Vogel, Andre C., et al.
Publicado: (2020) -
Risk factors for COVID-19 infection in patients with multiple sclerosis: a nested case–control study
por: Uhr, Lauren, et al.
Publicado: (2021) -
The how’s and what’s of vaccine reactogenicity
por: Hervé, Caroline, et al.
Publicado: (2019) -
Appendicitis
por: McBurney, Charles
Publicado: (1895) -
How to think like a psychologist : critical thinking in psychology /
por: McBurney, Donald, 1938-
Publicado: (1996)